Assessment of the Construct Validity of the Lupus Low Disease Activity State (LLDAS) - an Expert Opinion Case Study

被引：0
|
作者：
Golder, Vera [1 ]
Huq, Molla [2 ]
Franklyn, Kate [3 ]
Calderone, Alicia [4 ]
Lateef, Aisha [5 ]
Lau, Chak Sing [6 ]
Navarra, Sandra V. [7 ]
Godfrey, Timothy [4 ]
Oon, Shereen [4 ]
Hoi, Alberta Y. [3 ]
Morand, Eric F. [3 ]
Nikpour, Mandana [8 ]
机构：
[1] Monash Univ, Ctr Inflammatory Dis, Southern Clin Sch, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med Rheumatol, Melbourne, Vic, Australia
[3] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia
[4] St Vincents Hosp, 63 Sutton St, Melbourne, Vic, Australia
[5] Natl Univ Hlth Syst, Med Rheumatol, Singapore, Singapore
[6] Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China
[7] Univ Santo Tomas Hosp, Rheumatol, Manila, Philippines
[8] Univ Melbourne, Melbourne, Vic, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
790
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impaired hand function and performance in activities of daily living in systemic lupus erythematosus, even in patients achieving lupus low disease activity state (LLDAS)
    Keramiotou, Kyriaki
    Anagnostou, Christos
    Konstantonis, George
    Kataxaki, Evangelia
    Sfikakis, Petros P.
    Tektonidou, Maria G.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (02)
  • [22] LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT
    Ugarte-Gil, M. F.
    Hanly, J.
    Urowitz, M. B.
    Gordon, C.
    Bae, S. C.
    Romero-Diaz, J.
    Sanchez-Guerrero, J.
    Bernatsky, S.
    Clarke, A. E.
    Wallace, D. J.
    Isenberg, D.
    Rahman, A.
    Merrill, J. T.
    Fortin, P.
    Gladman, D. D.
    Bruce, I. N.
    Petri, M. A.
    Ginzler, E. M.
    Dooley, M. A.
    Ramsey-Goldman, R.
    Manzi, S.
    Jonsen, A.
    Van Vollenhoven, R.
    Aranow, C.
    Mackay, M.
    Ruiz-Irastorza, G.
    Lim, S. S.
    Inanc, M.
    Kalunian, K. C.
    Jacobsen, S.
    Peschken, C.
    Kamen, D. L.
    Askanase, A.
    Pons-Estel, B.
    Alarcon, G. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 177 - 178
  • [23] Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort
    Altabas-Gonzalez, Irene
    Rua-Figueroa, Inigo
    Rubino, Francisco
    Mourino Rodriguez, Coral
    Hernandez-Rodriguez, Inigo
    Menor Almagro, Raul
    Uriarte Isacelaya, Esther
    Tomero Muriel, Eva
    Salman-Monte, Tarek C.
    Carrion-Barbera, Irene
    Galindo, Maria
    Rodriguez Almaraz, Esther M.
    Jimenez, Norman
    Ines, Luis
    Maria Pego-Reigosa, Jose
    RHEUMATOLOGY, 2023, 62 (03) : 1162 - 1169
  • [24] OPTIMIZING A DEFINITION OF LUPUS LOW DISEASE ACTIVITY STATE (LDA) FOR DAILY CLINICAL PRACTICE: SLE-DAS LDA VS LLDAS
    Assuncao, H.
    Jesus, D.
    Da Silva, J. A. P.
    Ines, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 60 - 61
  • [25] Validity of retrospective disease activity assessment in systemic lupus erythematosus
    ArceSalinas, A
    Cardiel, MH
    Guzman, J
    AlcocerVarela, J
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (05) : 846 - 849
  • [26] Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
    Piga, Matteo
    Floris, Alberto
    Cappellazzo, Giulia
    Chessa, Elisabetta
    Congia, Mattia
    Mathieu, Alessandro
    Cauli, Alberto
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [27] Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
    Matteo Piga
    Alberto Floris
    Giulia Cappellazzo
    Elisabetta Chessa
    Mattia Congia
    Alessandro Mathieu
    Alberto Cauli
    Arthritis Research & Therapy, 19
  • [28] Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
    Oon, Shereen
    Huq, Molla
    Golder, Vera
    Ong, Pei Xuan
    Morand, Eric F.
    Nikpour, Mandana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (05) : 629 - 633
  • [29] LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
    Ugarte-Gil, Manuel Francisco
    Gamboa-Cardenas, Rocio Violeta
    Reategui-Sokolova, Cristina
    Pimentel-Quiroz, Victor Roman
    Medina, Mariela
    Elera-Fitzcarrald, Claudia
    Zevallos, Francisco
    Pastor-Asurza, Cesar Augusto
    Lofland, Jeniffer
    Zazzetti, Federico
    Karyekar, Chetan S.
    Alarcon, Graciela S.
    Perich-Campos, Risto Alfredo
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [30] REMISSION AND LOW LUPUS DISEASE ACTIVITY (LLDAS) ARE ASSOCIATED WITH BETTER PATIENT-REPORTED OUTCOMES (PROS) IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Ugarte-Gil, Manuel F.
    Gamboa-Cardenas, Rocio
    Reategui-Sokolova, Cristina
    Pimentel-Quiroz, Victor
    Medina, Mariela
    Elera-Fitzcarrald, Claudia
    Cucho-Venegas, Jorge M.
    Rodriguez-Bellido, Zoila
    Pastor-Asurza, Cesar
    Alarcon, Graciela S.
    Perich-Campos, Risto
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S17 - S17
12345